News/Events
Prestigious fellowship election for NIHR Cambridge BRC researchers
The NIHR Cambridge BRC is delighted that three of our researchers have been elected as Fellows of the Academy of Medical Sciences.
Theme leads Professor Menna Clatworthy and Professor Ludovic Vallier, together with Read more
Cambridge study to trial widely used drug to protect healthcare staff from COVID-19.
The PROLIFIC study (ChemoPROphyLaxIs For covId-19 infeCtious disease) aims to determine whether hydroxychloroquine (HCQ), a widely used anti-malarial drug, is effective at preventing or reducing COVID-19 infection in frontline healthcare workers.Read more
Over 150 participants recruited to new COVID-19 research programme
A “library” of valuable biological samples from people with COVID-19, which will help scientists globally fight the virus, has recruited its 150th participant.Read more
Cambridge trial targets immune response to treat COVID-19 patients
A new national study, supported by the NIHR Cambridge Biomedical Research Centre and the Cambridge Clinical Trials Unit will test whether two drugs that are already in use to treat other immune-related conditions Read more
Genetic analysis reveals new causes of Primary Immunodeficiency (PID)
A UK-wide research collaboration through the National Institute for Health Research (NIHR) BioResource for Rare Diseases has combined whole genome sequencing (WGS) with a statistical program called BeviMed to predict the existence of disease-causing changes in the DNA of people with Primary Immunodeficiency (PID). Read more
NIHR Cambridge BRC and CRF begin working on new COVID-19 study
Research staff from NIHR Cambridge Clinical Research Facility (CRF) are being deployed onto the wards at Cambridge University Hospitals (CUH) to start using a new test for a research trial into COVID-19.Read more
Fast-track HRA review of COVID-19 studies
The Health Research Authority (HRA) is working with the rest of the research system to provide a coordinated process so that COVID-19 research can progress quickly, using a fast-track review process with bespoke Read more
First Addenbrooke’s Patient in National COVID-19 Trial
Today, Addenbrooke’s Hospital has enrolled our first patient into the national RECOVERY trial, led by Oxford researchers, which is hoping to identify potential treatments for COVID-19. The Randomised Evaluation of COVid-19 thERapY (RECOVERY) Read more
New National guidance for prioritising funding and support for COVID-19 research across the UK
Published by NIHR 26 March 2020:
Working with partners across the health and care system, NIHR is leading, enabling and delivering world-class COVID-19 research, a key element of the Government’s overall response to Read more
COVID-19 research studies at CUH
In response to the COVID-19 pandemic Cambridge University Hospitals has put in place measures to help researchers and research infrastructure deliver COVID-19 studies, whilst also supporting the care of patients with COVID-19 by Read more
Update on clinical research during the COVID-19 outbreak
UPDATE 7 APRIL 2020:
Approval process for COVID-19 related research
Locally, trials and studies need first to be reviewed by the Cambridge BRC/Covid-19 oversight committee before being submitted through the national NIHR prioritisation Read more
Medovate working with CUH team to bring life-saving upper GI therapy device to market
Medical device company Medovate has secured the exclusive rights to bring to market a pioneering endoscopic surgical device.
The new device, ENDOVAC, has the potential to dramatically improve survival of patients with life-threatening Read more
Discover more
If you would like more information about NIHR Cambridge BRC, please contact us.